Autres langues Assertio Holdings

Actions

ASRT

US04546C3043

Produits pharmaceutiques

Temps Différé Nasdaq Autres places de cotation 22:00:00 15/06/2026			Varia. 5j.	Varia. 1 janv.
23,50 ^USD	+0,09%		-.--%	+159,10%

16/06	Assertio Holdings finalise sa fusion avec Zydus Lifesciences	MT
16/06	Assertio Holdings, Inc. annonce des changements au sein de son conseil d'administration et de ses comités, effectifs au 16 juin 2026	CI

Autres langues

16/06	Assertio Holdings Completes Merger With Zydus Lifesciences
16/06	Assertio Holdings, Inc. Announces Board and Committee Changes, Effective June 16, 2026
16/06	Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027
16/06	Assertio Holdings, Inc.(NasdaqCM:ASRT) dropped from S&P TMI Index
16/06	Assertio Holdings, Inc.(NasdaqGM:ASRT) dropped from NASDAQ Composite Index
16/06	Zydus Worldwide DMCC completed the acquisition of Assertio Holdings, Inc..
19/05	Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT
13/05	Garda Therapeutics, Inc. cancelled the acquisition of Assertio Holdings, Inc..
13/05	Zydus Worldwide DMCC entered into definitive agreement to acquire Assertio Holdings, Inc. for approximately $160 million.
13/05	Assertio to be acquired by Zydus Worldwide DMCC for $23.50 per share in cash
13/05	Assertio Board Approves $23.50-Per-Share Sale to Zydus Worldwide DMCC
13/05	Zydus to Acquire Assertio for $166.4 Million
13/05	Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash
08/05	Assertio Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
08/05	Assertio and Garda mutually agree to delay launch of tender offer
08/05	Assertio and Garda Mutually Agree to Delay Launch of Tender Offer
05/05	Assertio and Garda mutually agree to postpone commencement of tender offer
05/05	Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer
04/05	Assertio's Acquisition Price by Garda Boosted to $21.80 a Share; Stock Surges 17%
04/05	Assertio announces amended and restated merger agreement with Garda Therapeutics
04/05	Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics
29/04	Assertio and Garda Mutually Agree to Extend Tender Offer Deadline
21/04	Assertio provides update on Garda Therapeutics tender process
21/04	Assertio Provides Update on Garda Therapeutics Tender Process
14/04	Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT